pregnancy on RA have been proposed, but a satisfactory explanation has yet to be established. The proposed mechanisms are summarised in several reviews' 3 22 and include the immunomodulating properties of female sex hormones, immunosuppression by the various pregnancy associated proteins-for example, a2 glycoprotein, pregnancy induced suppression of the cell mediated immunity, and alterations in the glycosylation of IgG.23 These mechanisms may also explain a postponement of RA onset to the postpartum period, but the difference in parity before disease onset is not so easily explained in this way. Some gradient in risk of RA with the number of pregnancies in parous women would be expected as a 'dose-response' in such biological mechanisms. If a common immunological dysfunction is responsible for infertility and subsequent development of RA this infertility should also be reflected in a smaller family size in women who later develop RA. Protection against RA by pregnancy but independent of the number of pregnancies may otherwise suggest a threshold mechanism. A tentative explanation might be that pregnancy, particularly early in life-as a radical immunological event-incites T cell repertoire changes resulting in 'vaccination' against RA. 24 When interpreting data on the divergence in parity between patients with RA and controls we must also consider that pregnancy is closely related to contraception and sexual life. Oral contraception probably protects against RA, but the lack of a dose-response relation and the many inconsistencies in the various studies have made it very difficult to find a plausible biological explanation. 25 study' showed that current users of oral contraceptives pre-eminently experienced a reduction in RA, which might be compatible with a direct immunosuppressive effect of the pill. Subsequent studies reporting a favourable effect of oral contraceptive use, however, failed to find a stronger effect in current users than in past users.2 4 13 Also, short term use seemed to be as effective as long term use, which suggests that a 'hit and run' effect independent of dose might be involved. It has been found that lines of T lymphocytes can induce or vaccinate against autoimmune arthritis,26 and sex hormones might affect this T cell repertoire.
The most recent studies on the oral contraceptive pill and the risk of RA have merely added to the confusion. The Seattle study reported preliminary findings of a considerable reduction in the risk of RA in current users of oral contraceptives compared with only a slight reduction in past users.7 Conversely, analyses of the most recent data of the Royal College of General Practitioners' oral contraception study showed, in contrast with their 1978 finding, that the relative risk of RA among current users of oral contraceptive has now approached unity and approximates the risk among former users.'2 The disappearance of the contrast between current and former users seemed to result from a declining trend in the incidence of RA among former and never users of oral contraceptive but not among the current users. A tentative interpretation of this phenomenon might be that wQmen who have never used the pill have nowadays taken on the same 'lifestyle' as pill users and are therefore experiencing the same protection against the development of RA.
It is increasingly being suggested that oral contraceptive use may in fact be a marker for some other causal factor which differs among the study subjects of the various studies. This idea has been supported by the inability to confirm Vandenbroucke's3 finding of a preventive effect of non-contraceptive hormones on the development of RA. 11 
